早期卵巢癌前哨淋巴结超分期方案研究
本研究对30例明显早期卵巢癌患者的前哨淋巴结(SLN)采用超分期方案处理,评估其可行性及成本。结果显示盆腔和腹主动脉旁SLN检出率分别为91.3%和90%,2例(6.6%)因淋巴结转移升级为IIIA1期,超分期有助于发现低体积转移。
要点
- 盆腔和腹主动脉旁SLN检出率分别为91.3%和90%,所有病例至少一个区域检出SLN。
- 2例(6.6%)因超分期发现淋巴结转移升级为IIIA1期,其中1例微转移升级为宏转移。
- 超分期成本因SLN数量而异,盆腔平均96.8€,腹主动脉旁平均124.5€。
核心结论
- 前哨淋巴结超分期方案对早期卵巢癌低体积转移检测至关重要,可提供可重复的信息。
研究设计与样本
- 研究纳入30例明显早期卵巢癌患者,其SLN按超分期方案处理,并报告成本。
主要发现
- 盆腔SLN检出率为91.3%,腹主动脉旁为90%,所有病例至少一个区域检出SLN。
- 平均检出SLN数量:盆腔2.1±1.4枚,腹主动脉旁2.7±1.5枚。
- 2例(6.6%)因淋巴结转移升级为IIIA1期,其中1例盆腔SLN微转移(1mm)经超分期升级为2.1mm宏转移。
- 超分期成本:盆腔平均96.8€(范围0-230.5€),腹主动脉旁平均124.5€(范围0-322.7€)。
临床怎么用
- 对早期卵巢癌患者实施前哨淋巴结超分期方案,以提高低体积转移的检出率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of the present study is to determine the role of sentinel lymph node (SLN) ultrastaging in apparent early-stage ovarian cancer. METHODS: We previously demonstrated the feasibility of SLN in early-stage ovarian cancer in a pilot study and in a clinical trial (NCT03452982). The SLN of the 30 patients involved in both were processed following an ultrastaging protocol. The cost of ultrastaging processing was also reported. RESULTS: A SLN was detected in up to 91.3% and 90% in the pelvic and para-aortic region, respectively. In all cases, a SLN was detected at least in one field, pelvic or para-aortic. The mean time from injection to SLN resection was 53.3 ± 20.3 min. Two of 30 (6.6%) patients had a contralateral SLN in the para-aortic field, but no patients had contralateral SLN within the pelvic field after injection. The mean number of harvested SLN was 2.1 ± 1.4 (range: 0-5) and 2.7 ± 1.5 (range: 0-7) in the pelvic and para-aortic region, respectively. Two patients were upgraded to stage IIIA1 because of lymph node metastasis. In the first case, based on single sections and haematoxylin and eosin (H&E) examination, a pelvic SLN micrometastasis (1 mm) was found on the first H&E section. By using the ultrastaging protocol, the size of the metastasis was increased to 2.1 mm (macrometastasis). In the same patient, the ultrastaging study of the inframesenteric para-cava SLNs found isolated tumour cells in the subcapsular and interfollicular lymph nodes sinus in one of the two SLN harvested (in one of the sections at the fourth and fifth ultrastage levels). The other upstaged case was a para-aortic macrometastasis in a patient in whom the SLN was not identified in the para-aortic field because of the absence of migration from the infundibulo-pelvic stump injection. The cost of ultrastaging in each patient depended on the total number of SLN retrieved, averaging 96.8 € (range: 0-230.5) and 124.5 € (range: 0-322.7€) for pelvic and para-aortic SLN, respectively. CONCLUSIONS: A uniform protocol for ultrastaging is essential for lower-volume metastasis detection and to provide reproducible information between upcoming studies, as evidence about SLN in ovarian cancer is growing.
引用
- Lago V, Montero B, López S, et al. Ultrastaging protocol in sentinel lymph node for apparent early stage ovarian cancer. Gynecol Oncol. 2021. PMID: 33712275. doi:10.1016/j.ygyno.2021.03.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。